BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer

PURPOSE: Adjuvant tamoxifen treatment revolutionized the management of estrogen receptor (ER) positive breast cancers to prevent cancer recurrence; however drug resistance compromises its clinical efficacy. The mechanisms underlying tamoxifen resistance are not fully understood and no robust biomark...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Gong, Chun, Man, Ellen PS, Tsoi, Ho, Lee, Terence KW, Paul, Lee, Mak, Sai-Ting, Wong, Lai-San, Luk, Mai-Yee, Rakha, Emad A., Green, Andrew R, Ellis, Ian O, Lam, Eric W-F, Cheung, Kwok-Leung, Khoo, Ui-Soon
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6038915/
https://ncbi.nlm.nih.gov/pubmed/29420220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2259
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados